Furthermore, we have initially identified seven distinct genes (AGR2, CCR2, CEBPD, CISH, CX3CR1, DEFB1, and FSTL1) as promising sensitive biomarkers that may influence the progression of DN through the regulation of immune inflammatory response. The gene discussed is DEFB1; the disease is liver dysplastic nodule.